MOS
20
4
KEY
53
3
ETR
71
2
LLY
47
-4
SLB
50
4
PM
56
-8
CSX
60
2
GM
57
2
L
60
2
PX
55
2
AMP
64
3
KR
48
-4
JNPR
63
3
SYF
65
7
NWL
35
-5
R
67
4
RSG
57
-7
MO
33
-2
HST
52
3
RCL
72
-2
MOS
20
4
KEY
53
3
ETR
71
2
LLY
47
-4
SLB
50
4
PM
56
-8
CSX
60
2
GM
57
2
L
60
2
PX
55
2
AMP
64
3
KR
48
-4
JNPR
63
3
SYF
65
7
NWL
35
-5
R
67
4
RSG
57
-7
MO
33
-2
HST
52
3
RCL
72
-2
Financhill
Back

Bio-Path Holdings Quote, Financials, Valuation and Earnings

The Next Tech Giant in Your Pocket?

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30

BPTH
Bio-Path Holdings

Last Price:
1.00
Seasonality Move:
9.55%

7 Day Trial

ALL ACCESS PASS

$ 7

Former Chicago Pit Trader Exposes Shocking Trading Advantage:

See How to Target Up to 383% OVERNIGHT

Bio-Path Holdings Price Quote

$1.00
-0.05 (-4.58%)
(Updated: September 18, 2024 at 6:55 PM ET)

Bio-Path Holdings Key Stats

Sell
30
Bio-Path Holdings (BPTH) is a Sell
Day range:
$0.97 - $1.05
52-week range:
$0.91 - $21.60
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.07%
Volume:
50.6K
Avg. volume:
618.5K
1-year change:
-87.22%
Market cap:
$2.7M
Revenue:
$0
EPS:
$-16.67

How Much Does Bio-Path Holdings Make?

Data Unavailable

Is Bio-Path Holdings Growing As A Company?

Data Unavailable

Bio-Path Holdings Stock Price Performance

  • Did Bio-Path Holdings Stock Go Up Last Month?
    Bio-Path Holdings share price went down by -29.19% last month
  • Did BPTH's Share Price Rise Over The Last Year?
    BPTH share price fell by -87.22% over the past 1 year

What Is Bio-Path Holdings 52-Week High & Low?

Bio-Path Holdings Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Bio-Path Holdings?

  • How Much Debt Does Bio-Path Holdings Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Bio-Path Holdings Have?
    Cash and short term investments quarterly total is $4M
  • What Is Bio-Path Holdings’s Book Value Per Share?
    Book value per share is 0.57

Is Bio-Path Holdings Cash Flow Positive?

  • What Is BPTH Cash Flow From Operations?
    Cash flow from operations (TTM) is -$8.9M
  • What Is Bio-Path Holdings’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $9.4M
  • What Is Bio-Path Holdings’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Bio-Path Holdings Return On Invested Capital

Data Unavailable

Bio-Path Holdings Earnings Date & Stock Price

Bio-Path Holdings Competitors

  • Who Are Bio-Path Holdings's Competitors?
    Below is a list of companies who compete with Bio-Path Holdings or are related in some way:
    • Aadi Bioscience Inc (AADI)
    • Actinium Pharmaceuticals Inc (ATNM)
    • Bristol-Myers Squibb Co (BMY)
    • NovaBay Pharmaceuticals Inc (NBY)
    • SELLAS Life Sciences Group Inc (SLS)

Bio-Path Holdings Dividend Yield

Bio-Path Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 24.68%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 20.00
Upside from Last Price: 1808.4%

Major Shareholders

  • How many BPTH shares are owned by institutional investors?
    209.7K BPTH shares are owned by institutional investors
  • How many BPTH shares are owned by insiders?
    0 BPTH shares are owned by insiders